comparemela.com

Latest Breaking News On - Maximof nougues - Page 1 : comparemela.com

Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Down 18.6% in March

Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Down 18.6% in March
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Maximof-nougues
Alanh-auerbach
Mackenzie-financial-corp
Puma-biotechnology-inc
Puma-biotechnology-company-profile
Nasdaq
Balyasny-asset-management
Puma-biotechnology
Get-free-report
Street-group

Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Update

Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Alanh-auerbach
Maximof-nougues
Securities-exchange-commission
Mackenzie-financial-corp
Balyasny-asset-management
Puma-biotechnology-inc
Nasdaq
Puma-biotechnology
Get-free-report
Exchange-commission

Puma Biotechnology (NASDAQ:PBYI) Receives Buy Rating from HC Wainwright

Puma Biotechnology (NASDAQ:PBYI) Receives Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Alanh-auerbach
Maximof-nougues
Puma-biotechnology-inc
Puma-biotechnology-company-profile
Mackenzie-financial-corp
Balyasny-asset-management
Puma-biotechnology
Free-report
Street-group
Asset-management

Puma Biotechnology's (PBYI) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $8.00 price target on the biopharmaceutical company’s stock. Separately, StockNews.com upgraded shares of Puma Biotechnology from a buy rating to a strong-buy rating in a […]

United-states
Maximof-nougues
Alanh-auerbach
Securities-exchange-commission
Mackenzie-financial-corp
Puma-biotechnology-inc
Balyasny-asset-management
Puma-biotechnology
Free-report
Exchange-commission
Street-group

Maximo F. Nougues Sells 15,682 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) CFO Maximo F. Nougues sold 15,682 shares of the stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $4.49, for a total transaction of $70,412.18. Following the completion of the sale, the chief financial officer now owns 128,666 shares […]

United-states
Maximof-nougues
Mackenzie-financial-corp
Prudential-financial-inc
Nasdaq
Puma-biotechnology-company-profile
Puma-biotechnology-inc
Balyasny-asset-management
Puma-biotechnology
Get-free-report
Street-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.